Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Icosavax, Inc. (ICVX)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 50,230,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Icosavax is a biopharmaceutical company utilizing its virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with a focus on respiratory diseases. Co.'s pipeline includes vaccine candidates targeting some of viral causes of pneumonia. Co.'s vaccine candidate IVX-A12 is a bivalent candidate, or a mixture of different VLP candidates. IVX-A12 combines IVX-121, a vaccine candidate designed to target respiratory syncytial virus, and IVX-241, a vaccine candidate designed to target human metapneumovirus. Co. is developing additional vaccine candidates to develop combination VLP vaccines targeting the viral causes of pneumonia in older adults.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 225,965 272,386 481,304
Total Sell Value $0 $3,496,502 $3,919,051 $6,446,684
Total People Sold 0 4 5 7
Total Sell Transactions 0 8 14 44
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 119
  Page 3 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kanesa-Thasan Niranjan Chief Medical Officer   •       –      –    2023-01-04 4 S $15.70 $1,670,460 D/D (106,373) 223,980     -
   Kanesa-Thasan Niranjan Chief Medical Officer   •       –      –    2023-01-04 4 OE $0.84 $249,298 D/D 106,373 330,353     -
   Holtzman Douglas Chief Scientific Officer   •       –      –    2022-12-15 4 S $11.14 $218,963 I/I (19,648) 2,792     -
   Bekiroglu Elizabeth General Counsel & Corp. Sec.   •       –      –    2022-09-08 4 AS $4.87 $8,835 D/D (1,813) 108,929     -
   Richardson Charles E SVP, Technical Operations   •       –      –    2022-08-02 4 AS $6.70 $2,487 D/D (371) 165,168     -
   Kanesa-Thasan Niranjan Chief Medical Officer   •       –      –    2022-08-02 4 AS $6.70 $3,640 D/D (543) 239,314     -
   Russo Thomas Joseph Chief Financial Officer   •       –      –    2022-08-02 4 AS $6.70 $3,318 D/D (495) 48,921     -
   Holtzman Douglas Chief Scientific Officer   •       –      –    2022-08-02 4 AS $6.70 $3,037 D/D (453) 293,258     -
   Simpson Adam K. Chief Executive Officer   •       •      –    2022-08-02 4 AS $6.70 $12,764 D/D (1,904) 291,869     -
   Cearley Cassia Chief Business Officer   •       –      –    2022-08-02 4 AS $6.70 $2,031 D/D (303) 131,738     -
   Richardson Charles E SVP, Technical Operations   •       –      –    2022-08-01 4 AS $6.64 $9,080 D/D (1,368) 165,539     -
   Kanesa-Thasan Niranjan Chief Medical Officer   •       –      –    2022-08-01 4 AS $6.64 $13,281 D/D (2,001) 239,857     -
   Russo Thomas Joseph Chief Financial Officer   •       –      –    2022-08-01 4 AS $6.64 $12,113 D/D (1,825) 49,416     -
   Holtzman Douglas Chief Scientific Officer   •       –      –    2022-08-01 4 AS $6.64 $61,973 D/D (9,337) 293,711     -
   Simpson Adam K. Chief Executive Officer   •       •      –    2022-08-01 4 AS $6.64 $46,575 D/D (7,017) 293,772     -
   Cearley Cassia Chief Business Officer   •       –      –    2022-08-01 4 AS $6.64 $7,421 D/D (1,118) 132,041     -
   Richardson Charles E SVP, Technical Operations   •       –      –    2022-07-29 4 AS $7.11 $3,405 D/D (479) 166,907     -
   Kanesa-Thasan Niranjan Chief Medical Officer   •       –      –    2022-07-29 4 AS $7.11 $4,982 D/D (701) 241,858     -
   Russo Thomas Joseph Chief Financial Officer   •       –      –    2022-07-29 4 AS $7.11 $4,542 D/D (639) 51,241     -
   Holtzman Douglas Chief Scientific Officer   •       –      –    2022-07-29 4 AS $7.11 $4,158 D/D (585) 303,048     -
   Simpson Adam K. Chief Executive Officer   •       •      –    2022-07-29 4 AS $7.11 $17,456 D/D (2,456) 300,789     -
   Cearley Cassia Chief Business Officer   •       –      –    2022-07-29 4 AS $7.11 $2,779 D/D (391) 133,159     -
   Simpson Adam K. Chief Executive Officer   •       •      –    2022-07-01 4 OE $0.84 $6,035 D/D 7,185 303,245     -
   Mcdade Mark Director   –       •      –    2022-04-01 4 B $7.10 $299,798 D/D 42,225 50,243 2.39     -
   Shah Rajeev M. Director   –       •       •   2022-03-29 4 B $4.75 $42,271 I/I 8,900 5,963,565 2.25     -
  119 Records found
  1  2  3  4  5   
  Page 3 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us